Ex Vivo Transfer of Nuclear Factor-κB Decoy Ameliorates Hepatic Cold Ischemia/Reperfusion Injury

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1504-1507

  Yoshizumi, T ^a   Ikeda, Y ^a   Kaneda, Y ^a   Sueishi, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGODEOXYNUCLEOTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL VIABILITY; COLD ISCHEMIA; CONTROLLED STUDY; EX VIVO GENE TRANSFER; LIVER; LIVER CELL; LIVER GRAFT; LIVER ISCHEMIA; LIVER TRANSPLANTATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; THERAPY EFFECT;

ALANINE TRANSAMINASE; ANIMALS; CYTOKINES; INFLAMMATION; INTERLEUKIN-8; L-LACTATE DEHYDROGENASE; LIPOSOMES; LIVER CIRCULATION; LIVER TRANSPLANTATION; MALE; NEUTROPHILS; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; RATS; RATS, INBRED BN; REPERFUSION INJURY; SENDAI VIRUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67249093360     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.10.101     Document Type: Article

References (25)

1. Pesonen E.J., Hockerstedt K., Makisalo H., et al. Transhepatic neutrophil and monocyte activation during clinical liver transplantation. Transplantation 69 (2000) 1458
2. Goto M., Takei Y., Kawano S., et al. Tumor necrosis factor and endotoxin in the pathogenesis of liver and pulmonary injuries after orthotopic liver transplantation in the rat. Hepatology 16 (1992) 487
3. Lichtman S.N., and Lemasters J.J. Role of cytokines and cytokine-producing cells in reperfusion injury to the liver. Semin Liver Dis 19 (1999) 171
4. Emre S., Schwartz M.E., Altaca G., et al. Safe use of hepatic allografts from donors older than 70 years. Transplantation 62 (1996) 62
5. Alexander J.W., and Zola J.C. Expanding the donor pool: use of marginal donors for solid organ transplantation. Clin Transplant 10 (1996) 1
6. Imamura H., Sutto F., Brault A., et al. Role of Kupffer cells in cold ischemia/reperfusion injury of rat liver. Gastroenterology 109 (1995) 189
7. Arii S., Monden K., Adachi Y., et al. Pathogenic role of Kupffer cell activation in the reperfusion injury of cold-preserved liver. Transplantation 58 (1994) 1072
8. Sankary H.N., Chong A., Foster P., et al. Inactivation of Kupffer cells after prolonged donor fasting improves viability of transplanted hepatic allografts. Hepatology 22 (1995) 1236
9. Brass C.A., and Roberts T.G. Hepatic free radical production after cold storage: Kupffer cell-dependent and -independent mechanisms in rats. Gastroenterology 108 (1995) 1167
10. Bradham C.A., Stachlewitz R.F., Gao W., et al. Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology 25 (1997) 1128
11. Kozaki K., Egawa H., Bermudez L., et al. Effects of pentoxifylline pretreatment on Kupffer cells in rat liver transplantation. Hepatology 21 (1995) 1079
12. Morishita R., Sugimoto T., Aoki M., et al. In vivo transfection of cis element "decoy" against nuclear factor-κB binding site prevents myocardial infarction. Nat Med 3 (1997) 894
13. Sakaguchi T., Sawa Y., Fukushima N., et al. A novel strategy of decoy transfection against nuclear factor-kappaB in myocardial preservation. Ann Thorac Surg 71 (2001) 624
14. Tomita N., Morishita R., Tomita S., et al. Transcription factor decoy for NF-kappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo. Gene Ther 7 (2000) 1326
15. Saeki Y., Matsumoto N., Nakano Y., et al. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Hum Gene Ther 8 (1997) 2133
16. Kawauchi M., Suzuki J., Morishita R., et al. Gene therapy for attenuating cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and nonhuman primates. Circ Res 87 (2000) 1063
17. Kamada N., and Calne R.Y. Orthotopic liver transplantation in the rat. Transplantation 28 (1979) 47
18. Colletti L.M., Kunkel S.L., Walz A., et al. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 3 (1996) 506
19. Zwacka R.M., Zhou W., Zhang Y., et al. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation. Nat Med 4 (1998) 698
20. Takahashi Y., Ganster R.W., Ishikawa T., et al. Protective role of NF-κB in liver cold ischemia/reperfusion injury: effects of IκB gene therapy. Transplant Proc 33 (2001) 602
21. Hur G.M., Ryu Y.S., Yun H.Y., et al. Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-kappaB. Biochem Biophys Res Commun 261 (1999) 917
22. Yamada S., Iida T., Tabata T., et al. Alcoholic fatty liver differentially induces a neutrophil-chemokine and hepatic necrosis after ischemia-reperfusion in rat. Hepatology 32 (2000) 278
23. Bilbao G., Contreras J.L., Gomez-Navarro J., et al. Genetic modification of liver grafts with an adenoviral vector encoding the Bcl-2 gene improves organ preservation. Transplantation 67 (1999) 775
24. Bradham C.A., Schemmer P., Stachlewitz R.F., et al. Activation of nuclear factor-kappaB during orthotopic liver transplantation in rats is protective and does not require Kupffer cells. Liver Transpl Surg 5 (1999) 282
25. Yoshizumi T., Yonemitsu Y., Ikeda Y., et al. Tumor necrosis factor α antisense transfer remarkably improves hepatic graft viability. Liver Int 26 (2006) 451